We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
AUM
$407M
AUM Growth
+$9.35M
Cap. Flow
-$201M
Cap. Flow %
-49.39%
Top 10 Hldgs %
52.21%
Holding
108
New
15
Increased
22
Reduced
26
Closed
8

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$2.47M
2
XOM icon
ExxonMobil
XOM
+$1.93M
3
BSX icon
Boston Scientific
BSX
+$1.85M
4
KKR icon
KKR & Co
KKR
+$1.71M
5
NVDA icon
NVIDIA
NVDA
+$1.7M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$4.52M
2
NET icon
Cloudflare
NET
+$3.16M
3
DDOG icon
Datadog
DDOG
+$2.54M
4
EQT icon
EQT Corp
EQT
+$1.89M
5
ATI icon
ATI
ATI
+$1.62M

Sector Composition

Rank Sector Weight
1 Technology 5.54%
2 Industrials 2.25%
3 Healthcare 2.08%
4 Consumer Discretionary 1.87%
5 Financials 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDGR icon
51
Schrodinger
SDGR
$1.4B
$412K 0.1%
+15,260
New +$427K
MODN
52
DELISTED
MODEL N, INC.
MODN
$379K 0.09%
13,299
-550
-4% -$14.5K
MELI icon
53
Mercado Libre
MELI
$98.4B
$363K 0.09%
240
-2,760
-92% -$4.52M
TYL icon
54
Tyler Technologies
TYL
$13.2B
$361K 0.09%
850
-60
-7% -$25.6K
DDOG icon
55
Datadog
DDOG
$88.6B
$358K 0.09%
2,900
-20,220
-87% -$2.54M
ITT icon
56
ITT
ITT
$19.4B
$354K 0.09%
+2,600
New +$322K
IOVA icon
57
Iovance Biotherapeutics
IOVA
$2.94B
$339K 0.08%
22,900
-4,390
-16% -$51.1K
XYL icon
58
Xylem
XYL
$28.8B
$330K 0.08%
2,550
DTE icon
59
DTE Energy
DTE
$28.6B
$325K 0.08%
2,894
HCAT icon
60
Health Catalyst
HCAT
$132M
$279K 0.07%
37,050
+7,950
+27% +$72.6K
HELE icon
61
Helen of Troy
HELE
$682M
$267K 0.07%
2,315
TXG icon
62
10x Genomics
TXG
$7.62B
$266K 0.07%
7,100
+2,410
+51% +$106K
SPY icon
63
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$262K 0.06%
500
-400
-44% -$199K
ABSI icon
64
Absci
ABSI
$1.59B
$247K 0.06%
+43,570
New +$196K
FOUR icon
65
Shift4
FOUR
$3.24B
$235K 0.06%
+3,550
New +$267K
PYXS icon
66
Pyxis Oncology
PYXS
$179M
$219K 0.05%
+51,360
New +$216K
D icon
67
Dominion Energy
D
$59.9B
$212K 0.05%
4,315
KRYS icon
68
Krystal Biotech
KRYS
$9.68B
$208K 0.05%
1,170
NBIX icon
69
Neurocrine Biosciences
NBIX
$16.5B
$200K 0.05%
+1,450
New +$198K
BMRN icon
70
BioMarin Pharmaceuticals
BMRN
$13.5B
$161K 0.04%
1,840
+70
+4% +$6.27K
KEYS icon
71
Keysight
KEYS
$58.7B
$159K 0.04%
1,015
-2,860
-74% -$440K
ABCL icon
72
AbCellera Biologics
ABCL
$2.98B
$158K 0.04%
+34,980
New +$178K
ATI icon
73
ATI
ATI
$31.3B
$128K 0.03%
2,500
-35,820
-93% -$1.62M
DOCS icon
74
Doximity
DOCS
$4.65B
$120K 0.03%
4,460
EQX icon
75
Equinox Gold
EQX
$13.6B
$120K 0.03%
19,900
-1,985
-9% -$9.21K

Similar funds

Pier 88 Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Pier 88 Investment Partners held 108 positions worth $407M, up 2.4% from $398M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pier 88 Investment Partners withdrew a net $201M in Q1 2024, closing 8 positions and reducing 26 holdings. Its most notable exit was EQT Corp, an estimated $1.89M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, down from 6.4% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Pier 88 Investment Partners opened a new position in Freshpet worth $2.96M.

  • Pier 88 Investment Partners's largest Q1 2024 buy was Freshpet: 25,590 shares worth $2.96M.
  • Pier 88 Investment Partners added most to Arista Networks in Q1 2024, an estimated $1.26M increase.
  • Pier 88 Investment Partners's biggest Q1 2024 reduction was Mercado Libre, cutting an estimated $4.52M.
  • Pier 88 Investment Partners fully exited EQT Corp in Q1 2024, selling an estimated $1.89M.
  • Pier 88 Investment Partners's ten largest holdings make up 52% of its $407M portfolio in Q1 2024.
  • Pier 88 Investment Partners opened 15 new positions and closed 8 in Q1 2024.
  • Pier 88 Investment Partners's portfolio value rose 2.4% quarter-over-quarter to $407M.

Based on Pier 88 Investment Partners's 13F filing for Q1 2024, filed 10 May 2024.